Anticoagulant therapy: we have to do better! A systematic review

被引:0
|
作者
Wiltink, Ed H. [1 ]
机构
[1] St Antonius Hosp, Dept Clin Pharm & Pharmacol, NL-3430 EM Nieuwegein, Netherlands
关键词
ADVERSE DRUG EVENTS; HOSPITAL ADMISSIONS; ATRIAL-FIBRILLATION; WARFARIN; ERRORS; PREVENTION; STROKE; RISK;
D O I
10.1136/ejhpharm-2013-000295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim Anticoagulant therapy is considered a high-risk medication strategy with a narrow therapeutic window and the need for close monitoring, particularly with vitamin K antagonists. The nature of the drugs as well as the way they are administered make it more likely mistakes will occur. At all stages of care, ambulatory as well as in hospital, avoidable medication errors are seen. This review was performed to elucidate the number and nature of medication errors with anticoagulants and to look at possibilities for improving anticoagulant therapy. Methods A literature review was performed in PubMed, Medline and other sources looking after articles concerning medication errors in which anticoagulants are separately mentioned. From these articles, the risk factors were identified. Results A total of 17 papers were selected where medication errors with anticoagulant drugs were described. It became clear that medication errors occur from the doctor prescribing the medication, to the compliance of the patient with taking the treatment, and all steps in between. Communication between caregivers and between caregivers and patients seems to be an important factor. Conclusions This review shows that improvement is possible throughout the whole anticoagulant medication chain, starting with instructions for those prescribing drugs to education for patients.
引用
收藏
页码:108 / 112
页数:5
相关论文
共 50 条
  • [21] Forest resilience under global environmental change: Do we have the information we need? A systematic review
    Ibanez, Ines
    Acharya, Kirk
    Juno, Edith
    Karounos, Christopher
    Lee, Benjamin R.
    McCollum, Caleb
    Schaffer-Morrison, Samuel
    Tourville, Jordon
    PLOS ONE, 2019, 14 (09):
  • [22] Palliative radiation therapy: Can we do better?
    Roos, Daniel
    Millar, Jeremy
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2024, 68 (03) : 303 - 306
  • [24] Mpox: What Have We Learned and How Do We Better Prepare for the Future?
    Judson, Seth D.
    Orkin, Chloe M.
    Gebo, Kelly
    JOURNAL OF INFECTIOUS DISEASES, 2025,
  • [25] Posttransplant Medical Adherence: What Have We Learned and Can We Do Better?
    Dew M.A.
    Posluszny D.M.
    DiMartini A.F.
    Myaskovsky L.
    Steel J.L.
    DeVito Dabbs A.J.
    Current Transplantation Reports, 2018, 5 (2) : 174 - 188
  • [26] Premature ejaculation: do we have effective therapy?
    Serefoglu, Ege Can
    Saitz, Theodore R.
    Trost, Landon
    Hellstrom, Wayne J. G.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2013, 2 (01) : 45 - 53
  • [27] ANTACIDS FOR PEPTIC-ULCER - DO WE HAVE ANYTHING BETTER
    BERSTAD, A
    WEBERG, R
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 : 32 - 41
  • [28] How We Do It: Tranexamic Acid Injection for Patients on Anticoagulant Therapy
    Selby, Thomas
    Call, Whitney
    Donnelly, Heidi
    DERMATOLOGIC SURGERY, 2023, 49 (05) : 529 - 530
  • [29] Evaluating the Quality of Cost-Effectiveness Literature in Breast Surgery: What Do We Do Well and How Can We Do Better? A Systematic Review
    Char, Sydney N.
    Bloom, Joshua A.
    DeMarco, Danielle
    Chatterjee, Abhishek
    AMERICAN SURGEON, 2022, 88 (11) : 2660 - 2669
  • [30] A Systematic Review of Medical Nutrition Therapy Guidelines for Liver Cirrhosis: Do We Agree?
    Theodoridis, Xenophon
    Grammatikopoulou, Maria G.
    Petalidou, Arianna
    Kontonika, Stamatia-Maria
    Potamianos, Spyros P.
    Bogdanos, Dimitrios P.
    NUTRITION IN CLINICAL PRACTICE, 2020, 35 (01) : 98 - 107